These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33808158)

  • 1. DEEPGEN
    Hermann BT; Pfeil S; Groenke N; Schaible S; Kunze R; Ris F; Hagen ME; Bhakdi J
    Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33808158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasma.
    Verma S; Moore MW; Ringler R; Ghosal A; Horvath K; Naef T; Anvari S; Cotter PD; Gunn S
    BMC Cancer; 2020 Oct; 20(1):945. PubMed ID: 33004033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a targeted gene sequencing panel for application to disparate cancers.
    McCabe MJ; Gauthier MA; Chan CL; Thompson TJ; De Sousa SMC; Puttick C; Grady JP; Gayevskiy V; Tao J; Ying K; Cipponi A; Deng N; Swarbrick A; Thomas ML; Lord RV; Johns AL; Kohonen-Corish M; O'Toole SA; Clark J; Mueller SA; Gupta R; McCormack AI; Dinger ME; Cowley MJ;
    Sci Rep; 2019 Nov; 9(1):17052. PubMed ID: 31745186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurately identifying low-allelic fraction variants in single samples with next-generation sequencing: applications in tumor subclone resolution.
    Stead LF; Sutton KM; Taylor GR; Quirke P; Rabbitts P
    Hum Mutat; 2013 Oct; 34(10):1432-8. PubMed ID: 23766071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data.
    Karimnezhad A; Palidwor GA; Thavorn K; Stewart DJ; Campbell PA; Lo B; Perkins TJ
    BMC Med Genomics; 2020 Oct; 13(1):156. PubMed ID: 33059707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes.
    Barnell EK; Waalkes A; Mosior MC; Penewit K; Cotto KC; Danos AM; Sheta LM; Campbell KM; Krysiak K; Rieke D; Spies NC; Skidmore ZL; Pritchard CC; Fehniger TA; Uppaluri R; Govindan R; Griffith M; Salipante SJ; Griffith OL
    JCO Clin Cancer Inform; 2019 Oct; 3():1-12. PubMed ID: 31618044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the performance of low-frequency variant calling tools for the detection of variants from short-read deep sequencing data.
    Xiang X; Lu B; Song D; Li J; Shu K; Pu D
    Sci Rep; 2023 Nov; 13(1):20444. PubMed ID: 37993475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management.
    Hung SS; Meissner B; Chavez EA; Ben-Neriah S; Ennishi D; Jones MR; Shulha HP; Chan FC; Boyle M; Kridel R; Gascoyne RD; Mungall AJ; Marra MA; Scott DW; Connors JM; Steidl C
    J Mol Diagn; 2018 Mar; 20(2):203-214. PubMed ID: 29429887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RareVar: A Framework for Detecting Low-Frequency Single-Nucleotide Variants.
    Hao Y; Xuei X; Li L; Nakshatri H; Edenberg HJ; Liu Y
    J Comput Biol; 2017 Jul; 24(7):637-646. PubMed ID: 28541743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OutLyzer: software for extracting low-allele-frequency tumor mutations from sequencing background noise in clinical practice.
    Muller E; Goardon N; Brault B; Rousselin A; Paimparay G; Legros A; Fouillet R; Bruet O; Tranchant A; Domin F; San C; Quesnelle C; Frebourg T; Ricou A; Krieger S; Vaur D; Castera L
    Oncotarget; 2016 Nov; 7(48):79485-79493. PubMed ID: 27825131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies.
    Thomas M; Sukhai MA; Zhang T; Dolatshahi R; Harbi D; Garg S; Misyura M; Pugh T; Stockley TL; Kamel-Reid S
    Arch Pathol Lab Med; 2017 Jun; 141(6):759-775. PubMed ID: 28557600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Oncomine
    Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
    Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
    de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
    PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Circulating Tumor DNA with a Single-Molecule Sequencing Analysis Validated for Targeted and Immunotherapy Selection.
    Atkins A; Gupta P; Zhang BM; Tsai WS; Lucas J; Javey M; Vora A; Mei R
    Mol Diagn Ther; 2019 Aug; 23(4):521-535. PubMed ID: 31209714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calling Chromosome Alterations, DNA Methylation Statuses, and Mutations in Tumors by Simple Targeted Next-Generation Sequencing: A Solution for Transferring Integrated Pangenomic Studies into Routine Practice?
    Garinet S; Néou M; de La Villéon B; Faillot S; Sakat J; Da Fonseca JP; Jouinot A; Le Tourneau C; Kamal M; Luscap-Rondof W; Boeva V; Gaujoux S; Vidaud M; Pasmant E; Letourneur F; Bertherat J; Assié G
    J Mol Diagn; 2017 Sep; 19(5):776-787. PubMed ID: 28826610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NGS for Sequence Variants.
    Teng S
    Adv Exp Med Biol; 2016; 939():1-20. PubMed ID: 27807741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annotation of Variant Data from High-Throughput DNA Sequencing from Tumor Specimens: Filtering Strategies to Identify Driver Mutations.
    Sun S; Thorson JA; Murray SS
    Methods Mol Biol; 2019; 1908():49-60. PubMed ID: 30649720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated approach to generate artificial samples with low tumor fraction for somatic variant calling benchmarking.
    Sergi A; Beltrame L; Marchini S; Masseroli M
    BMC Bioinformatics; 2024 May; 25(1):180. PubMed ID: 38720249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Next Generation Sequencing in Laboratory Medicine.
    Zhong Y; Xu F; Wu J; Schubert J; Li MM
    Ann Lab Med; 2021 Jan; 41(1):25-43. PubMed ID: 32829577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.